Weiss Multi-Strategy Advisers LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 109 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2016. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2021$350,000
-3.8%
12,493
-10.9%
0.01%
+14.3%
Q4 2020$364,000
-25.3%
14,019
+7.1%
0.01%
-46.2%
Q3 2020$487,000
+35.7%
13,091
+87.0%
0.01%
+30.0%
Q2 2020$359,000
+32.5%
7,000
-56.2%
0.01%
-16.7%
Q1 2016$271,000
-23.9%
16,0000.0%0.01%
-52.0%
Q4 2015$356,000
+50.8%
16,000
+60.0%
0.02%
+150.0%
Q3 2015$236,000
-93.2%
10,000
-76.4%
0.01%
-92.7%
Q2 2015$3,467,000
-6.4%
42,400
+6.0%
0.14%
-16.5%
Q1 2015$3,704,000
-8.4%
40,000
-60.0%
0.16%
+17.1%
Q4 2014$4,044,000
+451.0%
100,000
+233.3%
0.14%
+677.8%
Q3 2014$734,000
+54.5%
30,0000.0%0.02%
+80.0%
Q2 2014$475,000
+4.6%
30,0000.0%0.01%
+11.1%
Q1 2014$454,000
-44.9%
30,000
-50.0%
0.01%
-50.0%
Q4 2013$824,000
-78.2%
60,000
-70.0%
0.02%
-56.1%
Q3 2013$3,772,000200,0000.04%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2016
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders